This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 200 Users Online

Eye Health Products Market

Increasing prevalence of age-related macular degeneration to create lucrative demands for the market to further expand in the future

Eye Health Supplements is segmented by Various Ingredients - Lutein and Zeaxanthin | Antioxidants | Omega-3 Fatty Acids | Coenzyme Q10 | Flavonoids | Astaxanthin | Alpha-Lipoic Acid

Eye Health Products Market Outlook (2023-2033)

Worldwide revenue from the eye health products market was about US$ 2.5 Bn in 2022, with the global market estimated to surge ahead at a CAGR of 7.3% to reach a valuation of US$ 4.7 Bn by the end of 2033.

Eye Health Products Market Size (2022)

US$ 2.5 Bn

Projected Market Value (2033)

US$ 4.7 Bn

Global Market Growth Rate (2023-2033)

7.3% CAGR

Market Share of Top 5 Countries

55.3%

As assessed by Persistence Market Research, age-related macular degeneration (AMD) segment reached a market valuation at around US$ 1.8 Bn at the end of 2022. Overall, eye health products market sales account for approximately 3.8% revenue share in the global eye care market, which was valued at around US$ 66.6 Bn at the end of 2022.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of the Global Market from 2014 to 2022 Vs Market Outlook for 2023 to 2033

The global market for eye health products recorded a historic CAGR of 5.7% in the last 8 years from 2014 to 2022.

Several major and regional manufacturers and government bodies are actively trying to raise awareness about eye health due to the increase in the ageing population and the prevalence of eye-related disorders all across the globe. In order to reduce the costs of treatments, various public bodies are also trying to encourage people to use nutritional supplements and products as preventive medicine and maintenance of eye health.

Over the forecast period, the global market for eye health products will rise significantly due to the rising prevalence of eye disorders majorly in the elderly population. A range of eye problems are brought on by ageing and the patients require appropriate treatment and precautionary medicines to maintain eye health. The use of eye health products, such as supplements, is an efficient way to treat eye issues that arise with ageing.

With the use of the eye health products, a number of disorders can be treated, including macular degeneration, retinopathy, cataracts, infections, diabetes mellitus, optic neuritis, trachoma, and dry eye syndrome.

One of the main drivers of the market has been the increasing prevalence of myopia and cases of vision impairment, which are related to an increase in screen usage and engagement in virtual meetings while working from home. High myopia is linked to a higher risk of a number of degenerative eye diseases, including cataracts and glaucoma. The market is also being driven by the rising preference for eye health products among millennials who are more susceptible to myopia and digital eye fatigue.

The global market is thus likely to show high growth over the coming years at a CAGR of 7.3% and reach a global market size of US$ 4.7 Bn by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What Factors Will Drive the Market to Grow Over Forecast Period?

Focus on Developing Novel Eye Health Supplements, Expanding Distribution Channels and Advertisement and Branding Campaigns”

Currently, Lutein, Zeaxanthin, Vitamin A, and Vitamin C make up around 60% of all eye health products on the market. Companies are introducing innovative ingredient types that are beneficial to human eye health, such as astaxanthin, blueberries, omega-3 long chain PUFAs, DHA, and genistein, to differentiate their eye health products. Companies to verify the effectiveness of developing substances rarely use clinical studies.

  • For instance, in order to research the advantages of astaxanthin's constituent on eye health, Cyanotech Corporation carried out numerous clinical trial investigations.

To increase product sales and reach to more consumers, companies are utilizing various distribution channels. Super/hypermarkets, pharmacies, and retail stores account for the majority of sales of vitamin and mineral based products. However, due to increased internet usage and the convenience of online purchasing, e-commerce sales have increased dramatically over the previous years, and this trend is anticipated to continue. To expand the accessibility of their products among customers, many manufacturers of eye health products are utilizing new distribution channels by working with hypermarkets and online retailers.

  • For instance, Valeant Pharmaceuticals collaborated with Costco, Kroger, Walmart, Walgreens, Rite aid and Amazon to distribute its eye health products.

Due to changes in dietary patterns, sedentary lifestyles and increased screen usage & blue light exposure, customers in our fast-paced world are becoming more concerned with their health. Various social media platforms, the internet, TV advertisements, and articles are just a few of the ways where customers can find information about healthcare. These resources offer comprehensive details on eye care products and new product introductions by various companies. The information coming from these public sources is helping consumers to make purchases. Companies are also introducing various eye health-improving products in the market based on consumer interests.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Is there Any Impact on the Growth of the Global Market?

Stringent Regulatory Framework & Product Recalls”

During the projected period, the market's expansion is predicted to be hampered by stringent regulations surrounding manufacturing, product safety, and efficacy claims. Regional differences in regulations exist. Some regions do not permit any efficacy or health benefit claims, whereas others do.

Therefore, in order to avoid regulatory actions, manufacturers need be careful about the claims they choose to make on labels and while promoting their products.

  • In May 2022, following a regulatory check on some of the products of Golden Lab LLC, the FDA sent a warning letter to Golden Lab LLC after determining that representations regarding the company's numerous formulations and eye health supplements constituted drug claims. Products were discovered to be contaminated during an inspection of the company's manufacturing facility because they were stored under conditions that did not conform to current good manufacturing practice (cGMP) for nutritional supplements. The inability to assure the products' purity, strength, and composition as well as the lack of adequate documentation about the manufacture and batch control of the products were among these violations.

The product recalls and summons from the regulatory authorities varies in different regions. Summons and warnings can lead to uncommercial the products from the market, as a result, product recalls will impede the market growth.

  • In July 2019, the retail level recall of many eye drops and other products from Altaire Pharmaceuticals was initiated. Concerns that the products might not be sterile led to their recall. An uncomfortable or even severe infection from bacteria or fungi could result from using non-sterile eye drops.
Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country-wise Insights

Why is the U.S. Market Booming?

“Broad Availability of Eye Care Products”

The U.S. held majority of the market share at around 29.1% market share in the global eye health products market at the end of 2022.

One of the major factors for the dominance of the U.S. in the global market is the rising prevalence of chronic eye disorders, such as diabetic retinopathy, AMD, dry eye syndrome, and glaucoma, along with growing awareness, the widespread availability of commercialized eye health products and the presence of major players. For instance, Bausch & Lomb introduced ocutive eye performance vitamin supplements in the U.S. in 2019.

Will the Germany Be a Lucrative Market for the Manufacturers?

“Better Regulatory Scenarios for Veterinary Products”

With a 5.2% market share, Germany held a fair amount of share in global market at the end of 2022.

Germany will continue to lead the European region in the future due to increased R&D activities, rapidly developing insurance sectors, and increased demand for more effective and innovative eye health products. Additionally, the increasing efforts made by the players to create a fully functional supply chain system and distribution channels that would aid in the market's expansion by promptly meeting demands.

How is China Emerging as a Prominent Market for Eye Health Products?

“Large Patient Pool to Create High Demand for Eye Health Products”

China held around majority of the market share of about 8.0% of the global eye health products market in 2022.

The market in China is being driven by the presence of numerous local market players who provide effective and reasonably priced eye health supplements, as well as an expanding contract-manufacturing hub and the penetration of international players. Additionally, rising consumer awareness of eye health is helping the market expand. Moreover, the presence of vast patient pool suffering from eye disorders to drive the market further.

Category-wise Insights

Which Ingredient is widely adopted for Eye Health Products?

Majorly Preferred Supplement for Eye Health”

Lutein and zeaxanthin held majority of the segment market share of around 31.4% of the segment by the end of 2022.

The significant segment growth can be attributed to growing public awareness of the advantages of lutein and zeaxanthin supplements in the preventive and efficient treatment of a variety of eye disorders, primarily AMD, retinopathy, uveitis, and cataract. In addition, more and more clinicians and ophthalmologists’ recommendations for these supplements as effective treatment option for various eye disorders have aided in the segment’s dominance.

Which Indication is generating High Demand for Eye Health Products Worldwide?

“AMD – the Most Common Cause of Blindness”

Age-related macular degeneration held majority of the segment market share at around 69.8% of the segment by the end of 2022.

An increase in AMD prevalence worldwide has an impact on the market's growth. AMD is the third most prevalent cause of blindness worldwide, based on the estimates of the International Agency for the Prevention of Blindness (IAPB), and is the main cause of blindness in high-income countries with sizable ageing populations.

By 2020, there were around 196.0 million cases of macular degeneration worldwide, and the BrightFocus Foundation predicts that number would increase to 288.0 million by the end of 2040.

Which Form is Expected to Emerge as a Market Leader in the Future?

“Better Shelf-Life than Other Formulations”

Capsules segment held majority of the segment market share of about 43.5% at the end of 2022.

Due to their wide availability in various forms, there is an increase in consumer preference for eye health supplements in capsule formulations, which is helping the segment growth. Additionally, the segment is being driven by factors including capsules' widespread acceptance among patients of all age groups and their relative affordability when compared to other forms. Another reason boosting demand for capsule formulations is the long shelf life of capsules in comparison to other forms.

Competition Landscape

Major players in the global market for eye health supplements are competing for market share by acquiring local and small manufacturing companies. In order to increase their sales and market share, manufacturers are adopting advertisement strategies and online campaigns to advertise their products in the marketplace.

Key instances include:

  • In May 2022, LUMIFY® Redness Reliever Eye Drops from Bausch + Lomb was approved by Health Canada.
  • In Dec 2019, Bausch and Lomb Incorporated introduced the mini gel eye vitamins known as PreserVision AREDS 2 Formula in the U.S.

Similarly, recent developments have been tracked by the team at Persistence Market Research related to companies in the eye health products space, which are available in the full report.

Eye Health Products Industry Report Scope

Attribute

Details

Forecast Period

2023-2033

Historical Data Available for

2014-2022

Market Analysis

USD Million for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • BENELUX
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC
  • North Africa
  • South Africa

Key Market Segments Covered

  • Ingredient
  • Indication
  • Form
  • Region

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Key Companies’ Profile

  • The Nature's Bounty Co.
  • Pfizer Inc.
  • Amway International
  • Bausch + Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.

Customization & Pricing

Available upon Request

Key Segments Covered in Eye Health Products Industry Research

Ingredient:

  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic Acid
  • Other Ingredients

Indication:

  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye Syndrome
  • Other Indications

Form:

  • Tablet
  • Capsule
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • Pfizer Inc.
  • The Nature's Bounty Co.
  • Amway International
  • Bausch + Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.

- Frequently Asked Questions -

The global market is anticipated to value around US$ 4.7 Bn at the end of 2023.

Sales of the market are set to witness growth at a CAGR of 7.3% and be valued at around US$ 4.7 Bn by 2033.

Demand for the market increased at a 5.7% CAGR from 2014 to 2022.

U.S., China, Russia, Italy, and Japan accounted for the major share in the global market as of year 2022, holding around 55.3% market share.

The U.S. held around the majority of the market share of about 29.1% share of the global market in 2022.

Latin America accounts for around 8.9% share of the global market in 2023.

Japan market is expected to hold a share of about 6.0% in the global eye health products market in 2023.

Germany held around 5.2% of the global market share at the end of 2022.

The U.K. is expected to grow at a CAGR of 5.6% over the forecast period.

India is expected to grow at a CAGR of 6.6% over the forecast period.

Google translate